Skip to main content
. 2016 Aug 22;7(49):80493–80507. doi: 10.18632/oncotarget.11492

Figure 2. Kaplan–Meier analysis of female patients with ESCC.

Figure 2

A. Overall survival (OS) and B. disease-free survival (DFS) curves for female patients as a function of high or low KIF-2C expression.